Intra-Cellular: 3Q Earnings Snapshot
NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Wednesday reported a loss of $41.5 million in its third quarter.
On a per-share basis, the New York-based company said it had a loss of 76 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 85 cents per share.
Intra-Cellular shares have climbed 17 percent since the beginning of the year. The stock has increased 15 percent in the last 12 months.